1don MSN
Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the ...
Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...
2d
Investor's Business Daily on MSNViking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.Viking Therapeutics stock toppled Tuesday after the biotech company inked a $150 million manufacturing deal for its weight-loss drug, VK2735.
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
13h
Zacks.com on MSNViking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to NoteIn the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $29.73, denoting a +0.61% change from the preceding trading day.
We recently published a list of 10 Stocks Skyrocketing Today. In this article, we are going to take a look at where Viking ...
Today, Benzinga's options scanner spotted 8 options trades for Viking Therapeutics. This is not a typical pattern. The ...
Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...
Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...
US biopharma Viking Therapeutics developing therapies for metabolic and endocrine disorders, closed Tuesday’s trading 5% ...
In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report). The ...
Bullish option flow detected in Viking Therapeutics (VKTX) with 8,905 calls trading, 2x expected, and implied vol increasing over 15 points to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results